G&E
德英生物科技股份有限公司
G&E is a Taiwan TPEx-listed biotechnology company, as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| SR-T100 | — | Phase 2; suspended | Common Wart | — | 2023-09-14 | Trial registry |
Key events
- Business update (company filing)
Related Drugnews articles
No related articles in this language.